Kensington Investment Counsel’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-24,248
| Closed | -$1.31M | – | 109 |
|
|
2024
Q1 | $1.31M | Buy |
24,248
+2,780
| +13% | +$151K | 0.6% | 56 |
|
|
2023
Q4 | $1.1M | Sell |
21,468
-3,689
| -15% | -$189K | 0.58% | 60 |
|
|
2023
Q3 | $1.46M | Buy |
25,157
+1,480
| +6% | +$85.9K | 0.91% | 38 |
|
|
2023
Q2 | $1.51M | Buy |
23,677
+2,739
| +13% | +$175K | 0.96% | 38 |
|
|
2023
Q1 | $1.45M | Buy |
20,938
+4,639
| +28% | +$322K | 1.1% | 38 |
|
|
2022
Q4 | $1.17M | Sell |
16,299
-92
| -0.6% | -$6.62K | 0.92% | 49 |
|
|
2022
Q3 | $1.17M | Buy |
16,391
+765
| +5% | +$54.4K | 0.98% | 48 |
|
|
2022
Q2 | $1.2M | Sell |
15,626
-272
| -2% | -$20.9K | 1.03% | 43 |
|
|
2022
Q1 | $1.16M | Sell |
15,898
-631
| -4% | -$46.1K | 0.77% | 60 |
|
|
2021
Q4 | $1.03M | Buy |
+16,529
| New | +$1.03M | 0.6% | 75 |
|
|
2021
Q2 | $993K | Buy |
14,864
+460
| +3% | +$30.7K | 0.68% | 72 |
|
|
2021
Q1 | $909K | Buy |
14,404
+1,186
| +9% | +$74.8K | 0.68% | 71 |
|
|
2020
Q4 | $820K | Buy |
+13,218
| New | +$820K | 0.68% | 70 |
|